# EDGAR Filing Document

**Accession Number:** 0001720420
**File Stem:** 0001720420-26-000014
**Filing Date:** 2026-5
**Character Count:** 8338
**Document Hash:** 75f0a0d181a2c0bd886dd0b597a0deb2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001720420-26-000014.hdr.sgml**: 20260513

**ACCESSION NUMBER**: 0001720420-26-000014

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20260511

**ITEM INFORMATION**: Other Events

**FILED AS OF DATE**: 20260513

**DATE AS OF CHANGE**: 20260513

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** IBEX Ltd
- **CENTRAL INDEX KEY:** 0001720420
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 000000000
- **STATE OF INCORPORATION:** D0
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38442
- **FILM NUMBER:** 26974659

**BUSINESS ADDRESS:**
- **STREET 1:** 1717 PENNSYLVANIA AVENUE NW
- **STREET 2:** SUITE 825
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20006
- **BUSINESS PHONE:** (202)580-6200

**MAIL ADDRESS:**
- **STREET 1:** 1717 PENNSYLVANIA AVENUE NW
- **STREET 2:** SUITE 825
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20006

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** IBEX Holdings Ltd
- **DATE OF NAME CHANGE:** 20171023

?xml version='1.0' encoding='ASCII'? ibex-20260511

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

____________________________________________________________

**FORM 8-K**

____________________________________________________________

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d)**

**of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): May 11, 2026

____________________________________________________________

**IBEX Limited**

(Exact name of registrant as specified in its charter)

____________________________________________________________

---

| | | |
|:---|:---|:---|
| **Bermuda** | **001-38442** | **00-0000000** |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |

---

**1717 Pennsylvania Avenue NW, Suite 825**

**Washington, District of Columbia 20006**

(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: **(202) 580-6200**

**Not applicable**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

□ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

□ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

□ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

□ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of Each Class** | **Trading Symbol(s)** | **Name of Each Exchange on Which Registered** |
| **Common shares, par value of $0.000111650536** | **IBEX** | **Nasdaq Global Market** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ⌧

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; □

------

**Item 8.01. Other Events**

**Approval of Share Repurchase Plan**

On May 11, 2026, the Ibex Limited (the "Company") board of directors (the "Board") authorized a Share Repurchase Plan to commence on May 14, 2026 to repurchase up to US$20 million of the Company's common stock over a period of one (1) year.

The Company's proposed repurchases may be made from time to time through open market transactions at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on the market conditions and in accordance with applicable rules and regulations. The actual timing, number, and dollar amount of repurchase transactions will be determined by management at its discretion and will depend on a number of factors including, but not limited to, the market price of the Company's common shares, general market and economic conditions, and compliance with Rule 10b-18 and/or Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the "Exchange Act").

The Board will review the repurchase program periodically and may authorize adjustment of its terms and size or suspend or discontinue the program. The Company expects to fund the repurchases under this program with its existing cash balance.

The repurchase program does not obligate the Company to acquire any particular amount of common shares, and the repurchase program may be suspended or discontinued at any time at the Company's discretion.

**Item 9.01. Financial Statements and Exhibits** 

(d) Exhibits. &nbsp;&nbsp;&nbsp;&nbsp;

<u>[Exhibit 99.1](exhibit9912026sharerepurch.htm)</u>&nbsp;&nbsp;&nbsp;&nbsp;Press release, dated May 13, 2026, entitled "IBEX Limited Announces $20 Million Share Repurchase &nbsp;&nbsp;&nbsp;&nbsp;Program"

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **<u>IBEX LIMITED</u>** | **<u>IBEX LIMITED</u>** |
| | (Registrant) | (Registrant) |
| Date: May 13, 2026 | /s/ Robert Dechant | /s/ Robert Dechant |
| | (Signature) | (Signature) |
| | Name: | Robert Dechant |
| | Title: | Chief Executive Officer |

---

## Exhibit 99.1

EXHIBIT 99.1

**<u>For Immediate Release</u>**

**IBEX Limited Announces $20 Million Share Repurchase Program**

**WASHINGTON, May 13, 2026** -- IBEX Limited ("ibex") (Nasdaq: IBEX), a global leader in outsourced business services and AI-powered customer experience solutions, today announced that its Board of Directors has authorized a share repurchase program, under which the Company may repurchase up to $20 million of its common stock during the next 12 months (the "Share Repurchase Program").

"Our new repurchase program reflects our confidence in the strength of our business, financial position, and growth trajectory," said Bob Dechant, ibex CEO. "We remain focused on deploying capital thoughtfully and in a manner that drives value for our shareholders."

The Company's proposed repurchases may be made from time to time through open market transactions at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on the market conditions and in accordance with applicable rules and regulations. The timing and dollar amount of repurchase transactions will be subject to the Securities and Exchange Commission (the "SEC") Rule 10b-18 and/or Rule 10b5-1 requirements.

The Board will review the Share Repurchase Program periodically and may authorize adjustment of its terms and size or suspend or discontinue the program. The Company expects to fund the repurchases under this program with its existing cash balance and free cash flow. The repurchase program will be executed consistent with the Company's capital allocation strategy, which will continue to prioritize aggressive investments to grow the business.

The repurchase program does not obligate the Company to acquire any particular amount of common shares, and the repurchase program may be suspended or discontinued at any time at the Company's discretion.

**About ibex**

**Investor Contact**

Tom Colton and Greg Bradbury

Gateway Group, Inc.

949-574-3860

IBEX@gateway-grp.com

**Media Contact**

Dan Burris

ibex

Daniel.Burris@ibex.co

<br>